Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes
Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for m...
Gespeichert in:
| Veröffentlicht in: | Primary care diabetes 2023-10, Vol.17 (5), p.526-528 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 528 |
|---|---|
| container_issue | 5 |
| container_start_page | 526 |
| container_title | Primary care diabetes |
| container_volume | 17 |
| creator | Lan, Nick S.R. Hong, Regina S.Y. Ryan, Christopher Jenkins, Alicia J. Fegan, P. Gerry |
| description | Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.
•Low patient awareness of cardiovascular risk and cholesterol levels.•Patients preferred glucose management over lipid management.•Patients preferred lifestyle modifications over lipid-lowering medication.•Many patients would take a statin if recommended by their doctor.•Concerns of statin side-effects were common among patients. |
| doi_str_mv | 10.1016/j.pcd.2023.07.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2845656384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S175199182300133X</els_id><sourcerecordid>2845656384</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-5e3a9e231f0c36483c145e539d4edbae0706b7d5e3c698db63c04d19e01546bf3</originalsourceid><addsrcrecordid>eNp9kDtP5DAURi0E4v0DtkEuKUi4jmM7ERVCwK6EtBRQUViOfYM8mxe2B4l_j0cDlFv5Fud8kg8hvxiUDJi8XJWLdWUFFS9BlQBihxyyRjUFVAx2860EK9qWNQfkKMYVgGS8UfvkgCvBKynVIXl5NMnjlOiCweKS_DxFOvfUmuD8_G6iXQ8m0ODjvws6-MU7OprJvOK4kczkaEx5IUt-ouljQcqo86bDhPGE7PVmiHj69R6T57vbp5vfxcPf-z831w-F5YKnQiA3LVac9WC5rBtuWS1Q8NbV6DqDoEB2ymXMyrZxneQWasdaBCZq2fX8mJxvd5cwv60xJj36aHEYzITzOuqqqYUUkjd1RtkWtWGOMWCvl-BHEz40A71pqlc6N9WbphqUzk2zc_Y1v-5GdD_Gd8QMXG0BzJ989xh0tLmpRecD2qTd7P8z_wl-BId7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2845656384</pqid></control><display><type>article</type><title>Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Lan, Nick S.R. ; Hong, Regina S.Y. ; Ryan, Christopher ; Jenkins, Alicia J. ; Fegan, P. Gerry</creator><creatorcontrib>Lan, Nick S.R. ; Hong, Regina S.Y. ; Ryan, Christopher ; Jenkins, Alicia J. ; Fegan, P. Gerry</creatorcontrib><description>Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.
•Low patient awareness of cardiovascular risk and cholesterol levels.•Patients preferred glucose management over lipid management.•Patients preferred lifestyle modifications over lipid-lowering medication.•Many patients would take a statin if recommended by their doctor.•Concerns of statin side-effects were common among patients.</description><identifier>ISSN: 1751-9918</identifier><identifier>EISSN: 1878-0210</identifier><identifier>DOI: 10.1016/j.pcd.2023.07.005</identifier><identifier>PMID: 37532667</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Cardiovascular diseases ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - etiology ; Diabetes mellitus type 1 ; Diabetes Mellitus, Type 1 - diagnosis ; Diabetes Mellitus, Type 1 - drug therapy ; Dyslipidaemias ; Dyslipidemias - diagnosis ; Dyslipidemias - drug therapy ; Heart Disease Risk Factors ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects ; Lipids ; Risk Factors ; Statins, Risk factors</subject><ispartof>Primary care diabetes, 2023-10, Vol.17 (5), p.526-528</ispartof><rights>2023</rights><rights>Copyright © 2023 Primary Care Diabetes Europe. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-5e3a9e231f0c36483c145e539d4edbae0706b7d5e3c698db63c04d19e01546bf3</citedby><cites>FETCH-LOGICAL-c353t-5e3a9e231f0c36483c145e539d4edbae0706b7d5e3c698db63c04d19e01546bf3</cites><orcidid>0000-0001-8100-6209 ; 0000-0002-9713-0316 ; 0000-0003-0583-3717 ; 0000-0002-7222-7314 ; 0009-0007-0611-0891</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37532667$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lan, Nick S.R.</creatorcontrib><creatorcontrib>Hong, Regina S.Y.</creatorcontrib><creatorcontrib>Ryan, Christopher</creatorcontrib><creatorcontrib>Jenkins, Alicia J.</creatorcontrib><creatorcontrib>Fegan, P. Gerry</creatorcontrib><title>Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes</title><title>Primary care diabetes</title><addtitle>Prim Care Diabetes</addtitle><description>Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.
•Low patient awareness of cardiovascular risk and cholesterol levels.•Patients preferred glucose management over lipid management.•Patients preferred lifestyle modifications over lipid-lowering medication.•Many patients would take a statin if recommended by their doctor.•Concerns of statin side-effects were common among patients.</description><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Diabetes mellitus type 1</subject><subject>Diabetes Mellitus, Type 1 - diagnosis</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Dyslipidaemias</subject><subject>Dyslipidemias - diagnosis</subject><subject>Dyslipidemias - drug therapy</subject><subject>Heart Disease Risk Factors</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects</subject><subject>Lipids</subject><subject>Risk Factors</subject><subject>Statins, Risk factors</subject><issn>1751-9918</issn><issn>1878-0210</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kDtP5DAURi0E4v0DtkEuKUi4jmM7ERVCwK6EtBRQUViOfYM8mxe2B4l_j0cDlFv5Fud8kg8hvxiUDJi8XJWLdWUFFS9BlQBihxyyRjUFVAx2860EK9qWNQfkKMYVgGS8UfvkgCvBKynVIXl5NMnjlOiCweKS_DxFOvfUmuD8_G6iXQ8m0ODjvws6-MU7OprJvOK4kczkaEx5IUt-ouljQcqo86bDhPGE7PVmiHj69R6T57vbp5vfxcPf-z831w-F5YKnQiA3LVac9WC5rBtuWS1Q8NbV6DqDoEB2ymXMyrZxneQWasdaBCZq2fX8mJxvd5cwv60xJj36aHEYzITzOuqqqYUUkjd1RtkWtWGOMWCvl-BHEz40A71pqlc6N9WbphqUzk2zc_Y1v-5GdD_Gd8QMXG0BzJ989xh0tLmpRecD2qTd7P8z_wl-BId7</recordid><startdate>202310</startdate><enddate>202310</enddate><creator>Lan, Nick S.R.</creator><creator>Hong, Regina S.Y.</creator><creator>Ryan, Christopher</creator><creator>Jenkins, Alicia J.</creator><creator>Fegan, P. Gerry</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8100-6209</orcidid><orcidid>https://orcid.org/0000-0002-9713-0316</orcidid><orcidid>https://orcid.org/0000-0003-0583-3717</orcidid><orcidid>https://orcid.org/0000-0002-7222-7314</orcidid><orcidid>https://orcid.org/0009-0007-0611-0891</orcidid></search><sort><creationdate>202310</creationdate><title>Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes</title><author>Lan, Nick S.R. ; Hong, Regina S.Y. ; Ryan, Christopher ; Jenkins, Alicia J. ; Fegan, P. Gerry</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-5e3a9e231f0c36483c145e539d4edbae0706b7d5e3c698db63c04d19e01546bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Diabetes mellitus type 1</topic><topic>Diabetes Mellitus, Type 1 - diagnosis</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Dyslipidaemias</topic><topic>Dyslipidemias - diagnosis</topic><topic>Dyslipidemias - drug therapy</topic><topic>Heart Disease Risk Factors</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects</topic><topic>Lipids</topic><topic>Risk Factors</topic><topic>Statins, Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lan, Nick S.R.</creatorcontrib><creatorcontrib>Hong, Regina S.Y.</creatorcontrib><creatorcontrib>Ryan, Christopher</creatorcontrib><creatorcontrib>Jenkins, Alicia J.</creatorcontrib><creatorcontrib>Fegan, P. Gerry</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Primary care diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lan, Nick S.R.</au><au>Hong, Regina S.Y.</au><au>Ryan, Christopher</au><au>Jenkins, Alicia J.</au><au>Fegan, P. Gerry</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes</atitle><jtitle>Primary care diabetes</jtitle><addtitle>Prim Care Diabetes</addtitle><date>2023-10</date><risdate>2023</risdate><volume>17</volume><issue>5</issue><spage>526</spage><epage>528</epage><pages>526-528</pages><issn>1751-9918</issn><eissn>1878-0210</eissn><abstract>Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.
•Low patient awareness of cardiovascular risk and cholesterol levels.•Patients preferred glucose management over lipid management.•Patients preferred lifestyle modifications over lipid-lowering medication.•Many patients would take a statin if recommended by their doctor.•Concerns of statin side-effects were common among patients.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>37532667</pmid><doi>10.1016/j.pcd.2023.07.005</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-8100-6209</orcidid><orcidid>https://orcid.org/0000-0002-9713-0316</orcidid><orcidid>https://orcid.org/0000-0003-0583-3717</orcidid><orcidid>https://orcid.org/0000-0002-7222-7314</orcidid><orcidid>https://orcid.org/0009-0007-0611-0891</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1751-9918 |
| ispartof | Primary care diabetes, 2023-10, Vol.17 (5), p.526-528 |
| issn | 1751-9918 1878-0210 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2845656384 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Cardiovascular diseases Cardiovascular Diseases - diagnosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - etiology Diabetes mellitus type 1 Diabetes Mellitus, Type 1 - diagnosis Diabetes Mellitus, Type 1 - drug therapy Dyslipidaemias Dyslipidemias - diagnosis Dyslipidemias - drug therapy Heart Disease Risk Factors Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Lipids Risk Factors Statins, Risk factors |
| title | Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A04%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient%20perceptions%20of%20cardiovascular%20risk,%20lipid%20management%20and%20statins%20in%20type%201%20diabetes&rft.jtitle=Primary%20care%20diabetes&rft.au=Lan,%20Nick%20S.R.&rft.date=2023-10&rft.volume=17&rft.issue=5&rft.spage=526&rft.epage=528&rft.pages=526-528&rft.issn=1751-9918&rft.eissn=1878-0210&rft_id=info:doi/10.1016/j.pcd.2023.07.005&rft_dat=%3Cproquest_cross%3E2845656384%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2845656384&rft_id=info:pmid/37532667&rft_els_id=S175199182300133X&rfr_iscdi=true |